141 related articles for article (PubMed ID: 24438591)
1. Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation.
Grzesik P; Teichmann A; Furkert J; Rutz C; Wiesner B; Kleinau G; Schülein R; Gromoll J; Krause G
FEBS J; 2014 Mar; 281(5):1479-1492. PubMed ID: 24438591
[TBL] [Abstract][Full Text] [Related]
2. A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor.
Nakamura K; Yamashita S; Omori Y; Minegishi T
Mol Endocrinol; 2004 Jun; 18(6):1461-70. PubMed ID: 15031322
[TBL] [Abstract][Full Text] [Related]
3. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization.
Zhang M; Feng X; Guan R; Hébert TE; Segaloff DL
Cell Signal; 2009 Nov; 21(11):1663-71. PubMed ID: 19616090
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
[TBL] [Abstract][Full Text] [Related]
5. A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.
Galet C; Ascoli M
Mol Endocrinol; 2006 Nov; 20(11):2931-45. PubMed ID: 16803865
[TBL] [Abstract][Full Text] [Related]
6. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor.
Abell A; Liu X; Segaloff DL
J Biol Chem; 1996 Feb; 271(8):4518-27. PubMed ID: 8626807
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
[TBL] [Abstract][Full Text] [Related]
8. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor.
Min L; Ascoli M
Mol Endocrinol; 2000 Nov; 14(11):1797-810. PubMed ID: 11075813
[TBL] [Abstract][Full Text] [Related]
9. GIPC binds to the human lutropin receptor (hLHR) through an unusual PDZ domain binding motif, and it regulates the sorting of the internalized human choriogonadotropin and the density of cell surface hLHR.
Hirakawa T; Galet C; Kishi M; Ascoli M
J Biol Chem; 2003 Dec; 278(49):49348-57. PubMed ID: 14507927
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling.
Lazzaretti C; Secco V; Paradiso E; Sperduti S; Rutz C; Kreuchwig A; Krause G; Simoni M; Casarini L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375708
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.
Shinozaki H; Butnev V; Tao YX; Ang KL; Conti M; Segaloff DL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1194-204. PubMed ID: 12629106
[TBL] [Abstract][Full Text] [Related]
12. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues.
Galet C; Ascoli M
Mol Endocrinol; 2005 May; 19(5):1263-76. PubMed ID: 15677709
[TBL] [Abstract][Full Text] [Related]
13. Receptor activation of and signal generation by the lutropin/choriogonadotropin receptor. Cooperation of Asp397 of the receptor and alpha Lys91 of the hormone.
Ji I; Zeng H; Ji TH
J Biol Chem; 1993 Nov; 268(31):22971-4. PubMed ID: 8226810
[TBL] [Abstract][Full Text] [Related]
14. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor.
Latronico AC; Chai Y; Arnhold IJ; Liu X; Mendonca BB; Segaloff DL
Mol Endocrinol; 1998 Mar; 12(3):442-50. PubMed ID: 9514160
[TBL] [Abstract][Full Text] [Related]
15. Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor's Extracellular Hinge Region.
Grzesik P; Kreuchwig A; Rutz C; Furkert J; Wiesner B; Schuelein R; Kleinau G; Gromoll J; Krause G
Front Endocrinol (Lausanne); 2015; 6():140. PubMed ID: 26441830
[TBL] [Abstract][Full Text] [Related]
16. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomain of human gonadotropin receptors.
Vischer HF; Granneman JC; Bogerd J
Mol Endocrinol; 2003 Oct; 17(10):1972-81. PubMed ID: 12869592
[TBL] [Abstract][Full Text] [Related]
17. Identification of two amino acid residues on the extracellular domain of the lutropin/choriogonadotropin receptor important in signaling.
Huang J; Puett D
J Biol Chem; 1995 Dec; 270(50):30023-8. PubMed ID: 8530405
[TBL] [Abstract][Full Text] [Related]
18. Association of human follitropin (FSH) receptor with splicing variant of human lutropin/choriogonadotropin receptor negatively controls the expression of human FSH receptor.
Yamashita S; Nakamura K; Omori Y; Tsunekawa K; Murakami M; Minegishi T
Mol Endocrinol; 2005 Aug; 19(8):2099-111. PubMed ID: 15890674
[TBL] [Abstract][Full Text] [Related]
19. Exoloop 3 of the luteinizing hormone/choriogonadotropin receptor. Lys583 is essential and irreplaceable for human choriogonadotropin (hCG)-dependent receptor activation but not for high affinity hCG binding.
Ryu KS; Gilchrist RL; Ji I; Kim SJ; Ji TH
J Biol Chem; 1996 Mar; 271(13):7301-4. PubMed ID: 8631747
[TBL] [Abstract][Full Text] [Related]
20. Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.
Latronico AC; Segaloff DL
Mol Cell Endocrinol; 2007 Jan; 260-262():287-93. PubMed ID: 17055147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
